您使用提示模式 关闭

CYBO - VanEck Bionic Engineering UCITS ETF (USD) (Acc) (IE0005TF96I9)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
IE0005TF96I9
CYBO ISIN
交易所交易基金 (ETF)
基金类型
VanEck
提供商
17,59 USD
每股资产净值 | 2026-06-23
2022-12-02
成立日期
股息的支付
CEOGES
CFI
CYBO
代码
Formed
Status
Equity
投资项目
Biotech
部门
Global
地区分布
MVIS Global Bionic Healthcare ESG Index
基准
0.55 %
总成本比率
Physical
复制方法
11,1 百万 USD
基金资产总量 | 2026-06-23
11,08 百万 USD
股票类资产 | 2026-06-23
UCITS

最新数据在
添加比较项目

报价 (CYBO)

探索最全面的数据库

1 000 000

债券

80 234

股票

167 970

ETF & Funds

8万

指数

以最有效的方式跟踪您的投资组合

  • 债券筛选器
  • 观察列表
  • Excel 附加组件

价格动态的变化

Fund profile

The VanEck Bionic Engineering UCITS ETF seeks to replicate as close as possible the price and yield performance of the MVIS Global Bionic Healthcare ESG Index by investing in a portfolio comprised primarily of companies involved in medical implants and bionic enhancements for chronic diseases and functional impairments

CYBO profile

The VanEck Bionic Engineering UCITS ETF (USD) (Acc) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in Global. The VanEck fund’s base currency is USD and the share class was registered 02.12.2022 with unique ISIN - IE0005TF96I9. Main exchange is London S.E. (USD) and ticker symbol is CYBO. The total expense ratio is 0.55%. The VanEck Bionic Engineering UCITS ETF (USD) (Acc) pays dividends 0 time(s) per year.

其他 ETF 和基金提供商

相关 ETF 和基金

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    资产净值
    {{ item.expense_ratio }}
    总成本比率
你必须 注册 才能获得访问权